GAFFI is a renowned brand dedicated to reducing mortality in HIV-related fungal infections. They have developed a powerful strategy to enhance outcomes by prioritizing timely diagnosis and ensuring access to treatment for immunocompromised patients residing in low- to middle-income countries (LMICs). With a strong focus on HIV management in LMICs, GAFFI empowers healthcare professionals to effectively manage opportunistic fungal infections among people living with HIV.

They actively cultivate and empower regional and local hubs and networks, enabling them to provide cost-effective and efficient diagnostics and treatments. GAFFI is the sole organization committed to addressing the diagnostic deficiencies and treatment gaps in HIV-associated fungal diseases. With over 2 million fungal-related deaths annually, fungal infections rank as the 5th leading cause of death worldwide, and approximately 50% of HIV deaths are attributed to fungal infections.

GAFFI's well-established model has proven to be successful, with demonstrated success stories such as a project developed in Guatemala. By actively working towards their vision of a world without deaths from fungal infections, GAFFI continues to make a significant impact in improving global healthcare outcomes